SCHEMBL24753003

SCHEMBL24753003

Nc1ccc(O)c(Br)c1C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.42
GLA P06280 1/20 0.42
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA7 P43166 2/20 0.41
CA9 Q16790 2/20 0.41
CA14 Q9ULX7 2/20 0.41
KMT2A Q03164 4/20 0.39
MEN1 O00255 3/20 0.39
ALDH1A1 P00352 2/20 0.39
CYP3A4 P08684 2/20 0.39
THRB P10828 2/20 0.39
RECQL P46063 2/20 0.39
CASP7 P55210 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
PTGS2 P35354 2/20 0.39
KDR P35968 2/20 0.39
TNF P01375 1/20 0.39
HSPD1 P10809 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7823717 0.81 KDM4E (0.44) KDM4EGLACA12CA1CA2
SCHEMBL15439886 0.80 CA12 (0.52) KDM4EGLACA12CA1CA2
SCHEMBL7115336 0.78 CASP7 (0.47) KDM4EGLACA12CA1CA2
SCHEMBL31634590 0.78 CASP7 (0.47) KDM4EGLACA12CA1CA2
SCHEMBL13202508 0.78 SELL (0.46) KDM4ECA12CA1CA2CA7
SCHEMBL16416613 0.78 KEAP1 (0.46) KDM4EGLACA12CA1CA2
SCHEMBL3104246 0.78 KDM4E (0.41) KDM4EGLAKMT2AMEN1ALDH1A1
SCHEMBL7014413 0.78 DPP4 (0.45) KDM4EGLACA12CA1CA2
SCHEMBL31169197 0.77 SELL (0.50) KDM4ECA12CA1CA2CA7
SCHEMBL3822164 0.77 KMT2A (0.48) KDM4EGLACA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4351583-A1 THERAPEUTICS FOR THE DEGRADATION OF MUTANT BRAF C4 Therapeutics, Inc. (US) 2024-04-17 EP disclosed
WO-2022261250-A1 THERAPEUTICS FOR THE DEGRADATION OF MUTANT BRAF C4 THERAPEUTICS, INC. (US) 2022-12-15 WO disclosed
WO-2022261250-A1 THERAPEUTICS FOR THE DEGRADATION OF MUTANT BRAF C4 THERAPEUTICS, INC. (US) 2022-12-15 WO disclosed